Loading data...

Psilocybin and psilocin research index

Find psilocybin and psilocin papers, preprints, trials, and citations with clear source context.

Searches titles, authors, journals, identifiers, indexed metadata, and derived research topics. Use Filters to narrow by source, status, substance, study type, or date.

Database 4,959 indexed records Auto-updated on Aug 17, 2026 01:21 UTC

Executed search Sources: ClinicalTrials.gov 300 matching records are displayed.

Clear search

Database

4,740 Psilocybin Records 673 Psilocin Records 1,461 Journals 66 Research Topics

Published 4,221 Peer-reviewed / formal records Preprints 435 Marked as not peer reviewed Clinical trials 300 ClinicalTrials.gov records R toolkit visNetwork Bibliometrics, live SQLite analysis, HTML graph, and PDF export

Top journals 1,461 indexed journals

Journal	Records
Journal of psychopharmacology (Oxford, England)	147
Journal of psychoactive drugs	97
Frontiers in psychiatry	90
Psychopharmacology	85
Neuroscience Applied	57
Journal of Psychedelic Studies	48
Psychedelic medicine (New Rochelle, N.Y.)	39
Scientific reports	37
bioRxiv : the preprint server for biology	33
Biological Psychiatry	32

Research topics 66 topic filters

Depression 1,736 Receptor Pharmacology 1,282 Safety 1,201 Mechanism of Action 1,070 Review Article 1,070 Clinical Trial 975 Anxiety 882 Addiction 823 Pharmacology 753 General 537 Aging 524 Animal Study 524 Observational Study 515 Brain Imaging 481 Treatment-Resistant Depression 417 Emotional Processing 409 PTSD 400 Neuroplasticity 399

Source coverage 8 active sources

Source	Count	Share	Status
PubMed	2,567	51.8%	Active
OpenAlex	1,154	23.3%	Active
Crossref	404	8.1%	Active
ClinicalTrials.gov	300	6%	Active
Europe PMC	187	3.8%	Active
PsyArXiv	187	3.8%	Active
bioRxiv	122	2.5%	Active

Publication timeline 3,856 dated records

3,856 records since 2020

Annual records Cumulative line

Reset all

Keyword search Author

Substances Psilocybin 4740 Psilocin 673

Date range quick select Last month Last year Last 5 years All time Custom range

Executed search Sources: ClinicalTrials.gov 300 matching records are displayed.

Clear search

Filtered publication index

Search results

300 matching records for Sources: ClinicalTrials.gov.

Select for export

Evaluation of the Acceptability, Safety, Feasibility, and Efficacy of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans

Abstract available at the source but not redistributed here. Read at source.

Details

ClinicalTrials.gov 2023-05-25 Combat Stress

ClinicalTrials.gov CLINICAL TRIAL psilocybin Depression Anxiety PTSD Other More

Select for export

Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult Volunteers

Abstract available at the source but not redistributed here. Read at source.

Details

ClinicalTrials.gov 2023-05-19 University of Wisconsin, Madison

ClinicalTrials.gov CLINICAL TRIAL psilocybin Depression Addiction Clinical Trial Clinical Trial More

Select for export

A Phase 1 Study Comparing the Pharmacokinetics and Safety of Intravenous and Oral Psilocybin

Abstract available at the source but not redistributed here. Read at source.

Details

ClinicalTrials.gov 2023-05-15 University of Wisconsin, Madison

ClinicalTrials.gov CLINICAL TRIAL psilocybin psilocin Depression Anxiety Addiction Clinical Trial More

Select for export

Effects of Psilocybin in Anorexia Nervosa

Abstract available at the source but not redistributed here. Read at source.

Details

ClinicalTrials.gov 2023-05-06 Johns Hopkins University

ClinicalTrials.gov CLINICAL TRIAL psilocybin Depression Anxiety Eating Disorders Other More

Select for export

The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression

Abstract available at the source but not redistributed here. Read at source.

Details

ClinicalTrials.gov 2023-04-24 COMPASS Pathways

ClinicalTrials.gov CLINICAL TRIAL psilocybin Depression Safety Other More

Select for export

Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of Consciousness

Abstract available at the source but not redistributed here. Read at source.

Details

ClinicalTrials.gov 2023-03-29 University Hospital, Basel, Switzerland

ClinicalTrials.gov CLINICAL TRIAL psilocybin Receptor Pharmacology Consciousness Spirituality Other More

Select for export

Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects ("MELO"): A Blinded, Placebo-Controlled, Dose-Finding Study

Abstract available at the source but not redistributed here. Read at source.

Details

ClinicalTrials.gov 2023-03-20 Optimi Health Corporation

ClinicalTrials.gov CLINICAL TRIAL psilocybin psilocin Depression Anxiety Microdosing Clinical Trial More

Select for export

Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder

Abstract available at the source but not redistributed here. Read at source.

Details

ClinicalTrials.gov 2023-03-13 New York State Psychiatric Institute

ClinicalTrials.gov CLINICAL TRIAL psilocybin Depression Brain Imaging Receptor Pharmacology Other More

Select for export

SV2A Marker of Synaptogenesis in a Clinical Trial of Psilocybin for Depression

Abstract available at the source but not redistributed here. Read at source.

Details

ClinicalTrials.gov 2023-01-30 Washington University School of Medicine

ClinicalTrials.gov CLINICAL TRIAL psilocybin Depression Neuroplasticity Brain Imaging Clinical Trial More

Select for export

Pilot Trial of Visual Healing®, a Nature-themed Virtual Immersive Experience, to Optimize Set and Setting in Psilocybin-assisted Therapy for Alcohol Use Disorder

Abstract available at the source but not redistributed here. Read at source.

Details

ClinicalTrials.gov 2023-01-17 Keith Heinzerling

ClinicalTrials.gov CLINICAL TRIAL psilocybin Anxiety Addiction Mystical Experience Clinical Trial More

Select for export

NW Trauma Therapies, Chronic Illness of Chronic Depression, PTSD, MS, HIV, and SARS-CoV-2, Long Haulers Syndrome. Treatment of Unregulaaible Trauma by the Treatment of Enhanced Micro Dosing the Levels of 0.15, Thru 0.33, With a Maintenance Dose of 1 Gram Per Month for Neural Pathway Increase of Non Synthesized Psilocybin, Using the Actual Plant to Regulate the Highjacked Nervous System.

Abstract available at the source but not redistributed here. Read at source.

Details

ClinicalTrials.gov 2022-11-16 NWTraumatherapies

ClinicalTrials.gov CLINICAL TRIAL psilocybin Depression PTSD End-of-Life Distress Other More

Select for export

A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence

Abstract available at the source but not redistributed here. Read at source.

Details

ClinicalTrials.gov 2022-11-08 NYU Langone Health

ClinicalTrials.gov CLINICAL TRIAL psilocybin Depression Anxiety Addiction Other More

Select for export

The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.

Abstract available at the source but not redistributed here. Read at source.

Details

ClinicalTrials.gov 2022-10-25 Sheppard Pratt Health System

ClinicalTrials.gov CLINICAL TRIAL psilocybin Depression Safety Other More

Select for export

An Exploratory Open-Label, Phase 1b, Ascending Dose Study to Evaluate the Effects of Oral 3-[2-(Dimethylamino)Ethyl]-1h-indol-4-yl Dihydrogen Phosphate (Psilocybin, BPL-PSILO) on Cognition in Patients With Chronic Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)

Abstract available at the source but not redistributed here. Read at source.

Details

ClinicalTrials.gov 2022-10-12 Beckley Psytech Limited

ClinicalTrials.gov CLINICAL TRIAL psilocybin Headache / Migraine Clinical Trial Safety Clinical Trial More

Select for export

Multicentre Study To Assess Safety And Efficacy Of Psilocybin In Patients With Treatment-Resistant Depression Following Completion Of COMP 001 And COMP 003 Trials (P-TRD LTFU)

Abstract available at the source but not redistributed here. Read at source.

Details

ClinicalTrials.gov 2022-09-22 COMPASS Pathways

ClinicalTrials.gov CLINICAL TRIAL psilocybin Depression Treatment-Resistant Depression Safety Other More

Select for export

Prophylactic Effects of Psilocybin on Chronic Cluster Headache: an Open-label Clinical Trial and Neuroimaging Study

Abstract available at the source but not redistributed here. Read at source.

Details

ClinicalTrials.gov 2022-08-10 Gitte Moos Knudsen

ClinicalTrials.gov CLINICAL TRIAL psilocybin psilocin Chronic Pain Headache / Migraine Brain Imaging Clinical Trial More

Select for export

Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy

Abstract available at the source but not redistributed here. Read at source.

Details

ClinicalTrials.gov 2022-07-25 University of California, San Diego

ClinicalTrials.gov CLINICAL TRIAL psilocybin Depression Anxiety Addiction Clinical Trial More

Select for export

Randomized Double Blind Placebo Controlled Assessing the Efficacy of Micro-dosed Psilocybin in Reducing Anxiety and or Depression Levels in Adults

Abstract available at the source but not redistributed here. Read at source.

Details

ClinicalTrials.gov 2022-06-30 Wake Network, Inc.

ClinicalTrials.gov CLINICAL TRIAL psilocybin Depression Anxiety Wellbeing Clinical Trial More

Select for export

Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant Depression

Abstract available at the source but not redistributed here. Read at source.

Details

ClinicalTrials.gov 2022-05-20 National Institute of Mental Health, Czech Republic

ClinicalTrials.gov CLINICAL TRIAL psilocybin psilocin Depression Neuroplasticity Brain Imaging Clinical Trial More

Select for export

Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression

Abstract available at the source but not redistributed here. Read at source.

Details

ClinicalTrials.gov 2022-04-29 University of Zurich

ClinicalTrials.gov CLINICAL TRIAL psilocybin Depression Anxiety Neuroplasticity Clinical Trial More